PLIKSMSAPI
What this is
The objective of the Scheme is to attain self-reliance and reduce import dependence in critical KSMs/DIs/APIs. Under the Scheme, financial incentives shall be given based on threshold investment and domestic sales made by selected applicant for the eligible products.
In detail
The scheme "Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India" by the Department of Pharmaceuticals, Ministry Of Chemicals And Fertilizers, Government of India aims to boost domestic manufacturing of identified Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) through providing financial incentives on incremental sales to manufacturers. The scheme focuses on 41 identified products covering critical APIs to reduce import dependence.
It is applicable only for greenfield projects and encourages large investments in the pharmaceutical sector.
- Tenure of the Scheme: The tenure of the scheme is from FY 2020-21 to FY 2029-30.
- Base Year: Financial Year 2019-20.
- Financial Outlay: Total financial outlay of the scheme is Rs. 6,940 crore.
- Basis of Computation: Assessment of threshold investment and sales of manufactured products shall be based on details furnished to the Departments/Ministries/Agencies and Statutory Auditor certificates.
- Project Management Agency: The scheme is implemented through a Nodal Agency, namely Industrial Finance Corporation of India (IFCI), which acts as the Project Management Agency (PMA).
Who qualifies
- Applicability: The scheme is applicable only for greenfield projects.
- Eligibility
- Support under the scheme shall be provided only to manufacturers of critical KSMs/DIs and APIs registered in India.
- Eligibility shall be subject to threshold investment in green field projects as given in the below-table.
- Eligibility under the scheme shall not affect eligibility under any other scheme and vice-versa.
> Eligibility Threshold Criteria:
S. NoSegmentThreshold Investment1.Fermentation based 04 KSMs /Drug Intermediates₹400,00,00,000/-2.Fermentation based 10 niche KSMs / Drug Intermediates / APIs₹50,00,00,000/-3.Key Chemical Synthesis based 04 KSMs /Drug Intermediates₹50,00,00,000/-4.Other 23 Chemical Synthesis based KSMs / Drug Intermediates / APIs₹20,00,00,000/-
What you get
> Financial Incentive on Sales:
- Incentive is provided on sales of 41 identified products for 6 years.
> Target Segments:
- Four Target Segments covering 41 products are listed in Annexure B.
> For Fermentation-Based Products:
- 20% incentive from FY 2023-24 to FY 2026-27.
- 15% incentive in FY 2027-28.
- 5% incentive in FY 2028-29.
> For Chemical Synthesis-Based Products:
- 10% incentive from FY 2022-23 to FY 2027-28.
> Coverage of Products:
- Incentives applicable for 41 products covering 53 critical APIs.
not about the scheme.
Provenance
| schemeName | Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India | myScheme · 2026-09-02 |
| schemeOpenDate | 2026-07-21 | myScheme · 2026-09-02 |
| schemeCloseDate | ... | not published at source |
| nodalMinistryName | Ministry Of Chemicals And Fertilizers | myScheme · 2026-09-02 |
| dbtScheme | False | myScheme · 2026-09-02 |
| achievement data | ... | no source publishes this for any central scheme |